ReleaseWire Connect

An investor, who currently holds shares of Covance Inc. (NYSE:CVD), filed a lawsuit in effort to halt the proposed takeover of Covance Inc. by Laboratory Corporation of America Holdings for a value of approximately $105.12 per share.

A deadline is coming up on March 6, 2015 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of Miller Energy Resources Inc (NYSE: MILL) between December 16, 2009 and August 8, 2011.

An investor, who currently holds shares of Atlas Pipeline Partners, L.P. (NYSE:APL), filed a lawsuit in effort to halt the proposed takeover of Atlas Pipeline Partners, L.P. by Targa Resources Partners L.P for a value of $38.66 per share.

An investigation on behalf of current long-term investors in shares of Universal Health Services, Inc. (NYSE:UHS) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Universal Health Services.

An investigation on behalf of investors, who currently hold shares of Actuate Corp (NASDAQ:BIRT), was announced concerning whether the takeover of Actuate Corp. by OpenText for $6.60 per share is unfair to NASDAQ:BIRT stockholders.

A deadline is coming up on May 5, 2015 in the settlement reached in the securities class action lawsuit filed on behalf of investors who purchased shares of American International Group Inc (NYSE: AIG) between March 16, 2006 and September 16, 2008.

An investor, who currently holds shares of Oplink Communications, Inc (NASDAQ:OPLK), filed a lawsuit in effort to halt the proposed takeover of Oplink Communications, Inc by Koch Industries, Inc for $24.25 per share.

A deadline is coming up on December 29, 2014 in the lawsuit filed for investors of Willbros Group Inc (NYSE:WG) over alleged securities laws violations by Willbros Group.

An investigation on behalf of current long-term investors in shares of Kindred Biosciences Inc (NASDAQ:KIN) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Kindred Biosciences Inc.

An investigation on behalf of investors of Christopher & Banks Corporation (NYSE:CBK) shares over potential securities laws violations by Christopher & Banks and certain of its directors and officers in connection certain financial statements was announced.